Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review

被引:11
|
作者
Coste, Astrid [1 ]
Wong, Angel [1 ]
Bokern, Marleen [1 ]
Bate, Andrew [1 ,2 ]
Douglas, Ian J. [1 ]
机构
[1] LSHTM, Dept Noncommunicable Dis Epidemiol, London, England
[2] Global Safety, Brentford, England
关键词
drug safety surveillance; pharmacoepidemiology; pharmacovigilance; real world data; signal detection; systematic review; CONTROLLED CASE SERIES; SPONTANEOUS REPORTING DATABASE; SEQUENCE SYMMETRY ANALYSIS; LONGITUDINAL DATABASES; EMPIRICAL-ASSESSMENT; RISK IDENTIFICATION; ADVERSE EVENTS; SURVEILLANCE; CLAIMS; RECORDS;
D O I
10.1002/pds.5548
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Signal detection is a crucial step in the discovery of post-marketing adverse drug reactions. There is a growing interest in using routinely collected data to complement established spontaneous report analyses. This work aims to systematically review the methods for drug safety signal detection using routinely collected healthcare data and their performance, both in general and for specific types of drugs and outcomes. Methods We conducted a systematic review following the PRISMA guidelines, and registered a protocol in PROSPERO. MEDLINE, EMBASE, PubMed, Web of Science, Scopus, and the Cochrane Library were searched until July 13, 2021. Results The review included 101 articles, among which there were 39 methodological works, 25 performance assessment papers, and 24 observational studies. Methods included adaptations from those used with spontaneous reports, traditional epidemiological designs, methods specific to signal detection with real-world data. More recently, implementations of machine learning have been studied in the literature. Twenty-five studies evaluated method performances, 16 of them using the area under the curve (AUC) for a range of positive and negative controls as their main measure. Despite the likelihood that performance measurement could vary by drug-event pair, only 10 studies reported performance stratified by drugs and outcomes, in a heterogeneous manner. The replicability of the performance assessment results was limited due to lack of transparency in reporting and the lack of a gold standard reference set. Conclusions A variety of methods have been described in the literature for signal detection with routinely collected data. No method showed superior performance in all papers and across all drugs and outcomes, performance assessment and reporting were heterogeneous. However, there is limited evidence that self-controlled designs, high dimensional propensity scores, and machine learning can achieve higher performances than other methods.
引用
收藏
页码:28 / 43
页数:16
相关论文
共 48 条
  • [41] Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review
    Golder, Su
    Xu, Dongfang
    O'Connor, Karen
    Wang, Yunwen
    Batra, Mahak
    Hernandez, Graciela Gonzalez
    DRUG SAFETY, 2025, 48 (04) : 321 - 337
  • [42] Explainable artificial intelligence models using real-world electronic health record data: a systematic scoping review
    Payrovnaziri, Seyedeh Neelufar
    Chen, Zhaoyi
    Rengifo-Moreno, Pablo
    Miller, Tim
    Bian, Jiang
    Chen, Jonathan H.
    Liu, Xiuwen
    He, Zhe
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2020, 27 (07) : 1173 - 1185
  • [43] Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations
    Brown, Jeffrey S.
    Kulldorff, Martin
    Petronis, Kenneth R.
    Reynolds, Robert
    Chan, K. Arnold
    Davis, Robert L.
    Graham, David
    Andrade, Susan E.
    Raebel, Marsha A.
    Herrinton, Lisa
    Roblin, Douglas
    Boudreau, Denise
    Smith, David
    Gurwitz, Jerry H.
    Gunter, Margaret J.
    Platt, Richard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (03) : 226 - 234
  • [44] Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review
    Langton, Julia M.
    Blanch, Bianca
    Drew, Anna K.
    Haas, Marion
    Ingham, Jane M.
    Pearson, Sallie-Anne
    PALLIATIVE MEDICINE, 2014, 28 (10) : 1167 - 1196
  • [45] Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions
    Backenroth, Daniel
    Chase, Herbert
    Friedman, Carol
    Wei, Ying
    PLOS ONE, 2016, 11 (10):
  • [46] A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care data
    Abdulazeem, Hebatullah
    Whitelaw, Sera
    Schauberger, Gunther
    Klug, Stefanie J.
    PLOS ONE, 2023, 18 (09):
  • [47] Validation of automated sepsis surveillance based on the Sepsis-3 clinical criteria against physician record review in a general hospital population: observational study using electronic health records data
    Valik, John Karlsson
    Ward, Logan
    Tanushi, Hideyuki
    Mullersdorf, Kajsa
    Ternhag, Anders
    Aufwerber, Ewa
    Farnert, Anna
    Johansson, Anders F.
    Mogensen, Mads Lause
    Pickering, Brian
    Dalianis, Hercules
    Henriksson, Aron
    Herasevich, Vitaly
    Naucler, Pontus
    BMJ QUALITY & SAFETY, 2020, 29 (09) : 735 - 745
  • [48] Methodological and Ethical Implications of Using Remote Data Collection Tools to Measure Sexual and Reproductive Health and Gender-Based Violence Outcomes among Women and Girls in Humanitarian and Fragile Settings: A Mixed Methods Systematic Review of Peer-Reviewed Research
    Vahedi, Luissa
    Qushua, Najat
    Seff, Ilana
    Doering, Michelle
    Stoll, Carrie
    Bartels, Susan A.
    Stark, Lindsay
    TRAUMA VIOLENCE & ABUSE, 2023, 24 (04) : 2498 - 2529